Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-23

FDA Approved: MESALAMINE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approval of the original application (ANDA) for mesalamine, enabling its generic availability for the treatment of ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MESALAMINE (generic) (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)